271 related articles for article (PubMed ID: 21253495)
1. Pathobiology of hodgkin lymphoma.
Piccaluga PP; Agostinelli C; Gazzola A; Tripodo C; Bacci F; Sabattini E; Sista MT; Mannu C; Sapienza MR; Rossi M; Laginestra MA; Sagramoso-Sacchetti CA; Righi S; Pileri SA
Adv Hematol; 2011; 2011():920898. PubMed ID: 21253495
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's lymphoma: the pathologist's viewpoint.
Pileri SA; Ascani S; Leoncini L; Sabattini E; Zinzani PL; Piccaluga PP; Pileri A; Giunti M; Falini B; Bolis GB; Stein H
J Clin Pathol; 2002 Mar; 55(3):162-76. PubMed ID: 11896065
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology of hodgkin lymphoma.
Agostinelli C; Pileri S
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014040. PubMed ID: 24959337
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease: classification and differential diagnosis.
Harris NL
Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
Wang S; Medeiros LJ; Xu-Monette ZY; Zhang S; O'Malley DP; Orazi A; Zuo Z; Bueso-Ramos CE; Yin CC; Liu Z; Miranda RN; Young KH
Ann Diagn Pathol; 2014 Aug; 18(4):203-9. PubMed ID: 24852241
[TBL] [Abstract][Full Text] [Related]
6. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?
Harris NL
Ann Oncol; 1998; 9 Suppl 5():S45-56. PubMed ID: 9926237
[TBL] [Abstract][Full Text] [Related]
7. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
Peh SC; Kim LH; Poppema S
Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
[TBL] [Abstract][Full Text] [Related]
8. [Hodgkin lymphoma. Classification and pathogenesis].
Foss HD; Marafioti T; Stein H
Pathologe; 2000 Mar; 21(2):113-23. PubMed ID: 10840817
[TBL] [Abstract][Full Text] [Related]
9. [WHO classification of Hodgkin's lymphoma and its molecular pathological relevance].
Hansmann ML; Willenbrock K
Pathologe; 2002 May; 23(3):207-18. PubMed ID: 12089788
[TBL] [Abstract][Full Text] [Related]
10. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
[TBL] [Abstract][Full Text] [Related]
12. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype.
Chang KC; Khen NT; Jones D; Su IJ
Hum Pathol; 2005 Jul; 36(7):747-55. PubMed ID: 16084943
[TBL] [Abstract][Full Text] [Related]
14. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
15. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma.
Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].
Wang JF; Wang YZ; Chen ZW; Taylor RC
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):218-23. PubMed ID: 16776979
[TBL] [Abstract][Full Text] [Related]
17. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
Cool CD; Bitter MA
Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin lymphoma: an update on its biology with new insights into classification.
Mani H; Jaffe ES
Clin Lymphoma Myeloma; 2009 Jun; 9(3):206-16. PubMed ID: 19525189
[TBL] [Abstract][Full Text] [Related]
19. Epstein Barr virus latent membrane protein-1 in Hodgkin's lymphoma in Nigerians.
Adelusola KA; Titiloye NA; Rotimi O; Durosinmi M
Afr Health Sci; 2009 Sep; 9(3):174-8. PubMed ID: 20589147
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia.
Peh SC; Looi LM; Pallesen G
Histopathology; 1997 Mar; 30(3):227-33. PubMed ID: 9088951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]